Novartis unit to take $120 million charge on recall

ZURICH (Reuters) – Novartis’s consumer health unit will take a $ 120 million hit in the fourth quarter after the Swiss drugmaker decided to voluntarily recall some products in the United States and move to improve quality standards at manufacturing sites.

This entry was posted in Business and tagged , , , , , , . Bookmark the permalink.

 

Our keys

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>